Jensen Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184M Sell
153,735
-76,936
-33% -$78.6M 4.47% 9
2026
Q1
$212M Sell
230,671
-19,156
-8% -$19.4M 4.18% 9
2025
Q4
$268M Sell
249,827
-213,912
-46% -$205M 4.22% 6
2025
Q3
$354M Buy
463,739
+257,127
+124% +$191M 4.39% 8
2025
Q2
$161M Buy
+206,612
New +$161M 1.89% 22
2014
Q3
Sell
-7,720
Closed -$480K 97
2014
Q2
$480K Sell
7,720
-1,400
-15% -$83.5K 0.01% 57
2014
Q1
$537K Sell
9,120
-900
-9% -$50.2K 0.01% 59
2013
Q4
$511K Buy
10,020
+1,620
+19% +$81.1K 0.01% 63
2013
Q3
$423K Buy
+8,400
New +$440K 0.01% 71

Other funds holding LLY

Jensen Investment Management's LLY Position: Q2 2026 in Review

Jensen Investment Management reduced its Eli Lilly (LLY) stake by 33% in Q2 2026, selling an estimated $78.6M and leaving 153,735 shares worth $184M. The position accounts for 4.47% of the portfolio, ranked #9.

Jensen Investment Management first reported a position in LLY in Q3 2013 and has held it in 9 quarters since. The position peaked at $354M in Q3 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jensen Investment Management held 153,735 shares of Eli Lilly worth $184M as of Q2 2026.
  • Jensen Investment Management sold 76,936 Eli Lilly shares in Q2 2026, an estimated $78.6M.
  • Eli Lilly made up 4.47% of Jensen Investment Management's portfolio in Q2 2026, its #9 holding.
  • Jensen Investment Management first reported a position in Eli Lilly in Q3 2013 and has held it in 9 quarters since.
  • Jensen Investment Management's Eli Lilly position peaked at $354M in Q3 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jensen Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.